| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AAV vector immunotoxicity: Stopping the domino effect
|
Asokan, Aravind
|
|
|
31 |
12 |
p. 3357-3358
|
artikel
|
| 2 |
A genetically encoded protein tag for control and quantitative imaging of CAR T cell therapy
|
Lee, Iris K.
|
|
|
31 |
12 |
p. 3564-3578
|
artikel
|
| 3 |
Apoptosis in mesenchymal stromal cells activates an immunosuppressive secretome predicting clinical response in Crohn’s disease
|
Cheung, Tik Shing
|
|
|
31 |
12 |
p. 3531-3544
|
artikel
|
| 4 |
Apoptotic MSCs, COX2/PGE2 and clinical efficacy in Crohn fistula
|
English, Karen
|
|
|
31 |
12 |
p. 3364-3366
|
artikel
|
| 5 |
A promoterless AAV6.2FF-based lung gene editing platform for the correction of surfactant protein B deficiency
|
Thomas, Sylvia P.
|
|
|
31 |
12 |
p. 3457-3477
|
artikel
|
| 6 |
Bypassing pre-existing antibodies extends the applicability of AAV-based retinal therapies
|
Hu, Hannah F.
|
|
|
31 |
12 |
p. 3363
|
artikel
|
| 7 |
Complete remission of tumors in mice with neoantigen-painted exosomes and anti-PD-1 therapy
|
Zhang, Yang
|
|
|
31 |
12 |
p. 3579-3593
|
artikel
|
| 8 |
Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village
|
Ao, Yong-Qiang
|
|
|
31 |
12 |
p. 3389-3413
|
artikel
|
| 9 |
Dual AAV-based PCDH15 gene therapy achieves sustained rescue of visual function in a mouse model of Usher syndrome 1F
|
Riaz, Sehar
|
|
|
31 |
12 |
p. 3490-3501
|
artikel
|
| 10 |
FUNDC1/PFKP-mediated mitophagy induced by KD025 ameliorates cartilage degeneration in osteoarthritis
|
Fang, Guibin
|
|
|
31 |
12 |
p. 3594-3612
|
artikel
|
| 11 |
Improved efficacy of FKRP AAV gene therapy by combination with ribitol treatment for LGMD2I
|
Cataldi, Marcela P.
|
|
|
31 |
12 |
p. 3478-3489
|
artikel
|
| 12 |
In this issue
|
|
|
|
31 |
12 |
p. 3362
|
artikel
|
| 13 |
Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasion
|
Kellish, Patrick C.
|
|
|
31 |
12 |
p. 3441-3456
|
artikel
|
| 14 |
In vivo genome editing shows promise for treating pulmonary diseases
|
Yan, Ziying
|
|
|
31 |
12 |
p. 3361
|
artikel
|
| 15 |
Myelodysplasia after clonal hematopoiesis with APOBEC3-mediated CYBB inactivation in retroviral gene therapy for X-CGD
|
Uchiyama, Toru
|
|
|
31 |
12 |
p. 3424-3440
|
artikel
|
| 16 |
Myelodysplasia and transgene inactivation in X-CGD-γ retroviral gene therapy: The usual suspects and new players
|
Whittaker, Thomas E.
|
|
|
31 |
12 |
p. 3367-3368
|
artikel
|
| 17 |
NIIMBL’s viral vector program: A cross-gene therapy community collaboration to transform viral vector development and manufacturing
|
Lee, Kelvin H.
|
|
|
31 |
12 |
p. 3359-3360
|
artikel
|
| 18 |
Redirecting AAV vectors to extrahepatic tissues
|
Asokan, Aravind
|
|
|
31 |
12 |
p. 3371-3375
|
artikel
|
| 19 |
RNA base editing therapy cures hearing loss induced by OTOF gene mutation
|
Xue, Yuanyuan
|
|
|
31 |
12 |
p. 3520-3530
|
artikel
|
| 20 |
Tagging CAR-T cells to enable control and quantitative imaging
|
Choyke, Peter L.
|
|
|
31 |
12 |
p. 3369-3370
|
artikel
|
| 21 |
The European landscape for gene therapies in orphan diseases: 6-year experience with the EMA Committee for Orphan Medicinal Products
|
Palomo, Gloria M.
|
|
|
31 |
12 |
p. 3414-3423
|
artikel
|
| 22 |
The state of cell and gene therapy in 2023
|
Chancellor, Daniel
|
|
|
31 |
12 |
p. 3376-3388
|
artikel
|
| 23 |
Third-generation lentiviral gene therapy rescues function in a mouse model of Usher 1B
|
Schott, Juliane W.
|
|
|
31 |
12 |
p. 3502-3519
|
artikel
|
| 24 |
Transplanted human neural stem cells rescue phenotypes in zQ175 Huntington’s disease mice and innervate the striatum
|
Holley, Sandra M.
|
|
|
31 |
12 |
p. 3545-3563
|
artikel
|
Tijdschrift beschrijving